Ingevity Corp Surpasses Analyst Price Target: What’s Next?

In recent trading, Ingevity Corp (Symbol: NGVT) saw its shares rise above the average analyst 12-month target price of $49.50, changing hands at $50.21 per share. When a stock exceeds the set target price, analysts must decide how to respond. They can either downgrade based on valuation concerns or raise their target if they believe the company’s outlook is improving. An analyst’s reaction often hinges on recent fundamental business developments that may be propelling the stock price upward.

Within the Zacks coverage universe, there are four different analyst targets contributing to the average for Ingevity Corp. It’s important to understand that the average is simply a mathematical value. Some analysts have lower price targets, with one suggesting $40.00, while another stands on the opposite end with a target as high as $58.00. The standard deviation among these targets is $7.767.

The reason to consider the average NGVT price target is to harness a “wisdom of crowds” approach. This means taking into account the insights of multiple analysts rather than relying solely on a single opinion. Now that NGVT has surpassed the average target price of $49.50 per share, investors face an important decision. Is $49.50 merely a stepping stone to an even higher price, or has the valuation stretched thin enough to warrant reevaluation and potential profit-taking?

The average rating shown above ranges from 1 to 5, where 1 means Strong Buy and 5 means Strong Sell. This article utilized data provided by Zacks Investment Research via Quandl.com. For more detailed insights, you can access the latest Zacks research report on NGVT — FREE.

The Top 25 Broker Analyst Picks of the S&P 500 »

Also see:

• REITs Hedge Funds Are Buying
• DOMH Videos
• Institutional Holders of BLIN

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.